ArticleOncotarget2014

Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells.

Yingying Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.